Prokidney provide specialized treatment for chronic kidney disease.
Prokidney has raised $140.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
Prokidney's investors include Social Capital, Suvretta Capital Management.
Prokidney is headquartered in Salem, United States.
Prokidney provide specialized treatment for chronic kidney disease.
Prokidney is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prokidney — Funding & Investors." VCBacked, June 11, 2024, https://www.vcbacked.co/company/prokidney. Accessed September 13, 2026.
VCBacked. (2024). Prokidney — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/prokidney
{{cite web |title=Prokidney — Funding & Investors |url=https://www.vcbacked.co/company/prokidney |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated